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Background: Rickettsia conorii is transmitted by Rhipicephalus sanguineus ticks and causes Mediterranean Spotted
Fever (MSF) in humans. Although dogs are considered the natural host of the vector, the clinical and epidemiological
significance of R. conorii infection in dogs remains unclear. The aim of this prospective study was to investigate whether
Rickettsia infection causes febrile illness in dogs living in areas endemic for human MSF.
Methods: Dogs from southern Italy with acute fever (n = 99) were compared with case–control dogs with normal body
temperatures (n = 72). Serology and real-time PCR were performed for Rickettsia spp., Ehrlichia canis, Anaplasma
phagocytophilum/A. platys and Leishmania infantum. Conventional PCR was performed for Babesia spp. and Hepatozoon
spp. Acute and convalescent antibodies to R. conorii, E. canis and A. phagocytophilum were determined.
Results: The seroprevalence rates at first visit for R. conorii, E. canis, A. phagocytophilum and L. infantum were 44.8%, 48.5%,
37.8% and 17.6%, respectively. The seroconversion rates for R. conorii, E. canis and A. phagocytophilum were 20.7%, 14.3%
and 8.8%, respectively. The molecular positive rates at first visit for Rickettsia spp., E. canis, A. phagocytophilum, A. platys,
L. infantum, Babesia spp. and Hepatozoon spp. were 1.8%, 4.1%, 0%, 2.3%, 11.1%, 2.3% and 0.6%, respectively. Positive PCR
for E. canis (7%), Rickettsia spp. (3%), Babesia spp. (4.0%) and Hepatozoon spp. (1.0%) were found only in febrile dogs. The
DNA sequences obtained from Rickettsia and Babesia PCRs positive samples were 100% identical to the R. conorii and
Babesia vogeli sequences in GenBank®, respectively. Febrile illness was statistically associated with acute and convalescent
positive R. conorii antibodies, seroconversion to R. conorii, E. canis positive PCR, and positivity to any tick pathogen PCRs.
Fourteen febrile dogs (31.8%) were diagnosed with Rickettsia spp. infection based on seroconversion and/or PCR while
only six afebrile dogs (12.5%) seroconverted (P = 0.0248). The most common clinical findings of dogs with Rickettsia
infection diagnosed by seroconversion and/or PCR were fever, myalgia, lameness, elevation of C-reactive protein,
thrombocytopenia and hypoalbuminemia.
Conclusions: This study demonstrates acute febrile illness associated with Rickettsia infection in dogs living in endemic
areas of human MSF based on seroconversion alone or in combination with PCR.
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Rickettsia conorii is a Spotted Fever Group (SFG) Rickettsia
that causes Mediterranean Spotted Fever (MSF) in humans
in Mediterranean countries and Sub-Saharan Africa. The
onset of MSF is abrupt and typical human cases present
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unless otherwise stated.tick bite site and a maculo-papular rash. Severe forms of
the disease may present with major neurological manifes-
tations and multi-organ involvement may occur. The mor-
tality rate is estimated at around 2.5% and classical risk
factors for severe forms include elderly age, cirrhosis,
chronic alcoholism and glucose-6-phosphate dehydrogen-
ase deficiency [1,2]. In Italy, more than 1000 human cases
of MSF are reported annually mainly in Sicily, Sardinia,
Lazio and Liguria [2,3]. Moreover, a more pathogenic
subspecies of R. conorii, R. conorii israelensis, has been de-
scribed in human cases in Sicily [4]. In addition, R. conoriiMed Central. This is an Open Access article distributed under the terms of the
reativecommons.org/licenses/by/4.0) which permits unrestricted use, distribution,
he original work is properly credited. The Creative Commons Public Domain
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human patients in Sicily [5].
The organism is transmitted in the Mediterranean
basin by the brown dog tick Rhipicephalus sanguineus.
Mediterranean spotted fever is a human seasonal disease
that is frequently diagnosed between April and October
with a maximum peak in June-August [2] and it is well
correlated with the presence of Rh. sanguineus. Ticks are
possibly the main reservoir of R. conorii infection due to
the existence of both transtadial and transovarial trans-
mission and cofeeding in this tick sp. [1,2,6]. The role of
dogs in maintaining zoonotic foci remains unclear [1].
Although dogs are the natural host of the vector, there is
limited information on their susceptibility to Rickettsiae
infection and on the development of long duration rick-
ettsiemia able to allow transmission to a feeding vector
tick [7]. However, experimental infections suggest that
dogs can be competent reservoirs for R. conorii [6,7].
Due to high levels of Rh. sanguineus exposure, dogs have
been used in epidemiological studies as sentinels for
human MSF [8] and proximity to seroreactive dogs has
been found as a risk factor for MSF in humans [9]. Several
studies have reported anti-R. conorii antibodies by the in-
direct fluorescent antibody test (IFA) in dogs in R. conorii
endemic countries such as Italy with seroprevalence rates
ranging from 15.5% to 74% [10]. The very high seropreva-
lences detected in Italian dogs would suggest frequent ex-
posure to Rickettsia spp. or persistent low-grade infection
with a rickettsial organism or organisms that cross react
with R. conorii antigens by IFA testing.
Studies reported the detection of Rickettsia DNA in
the blood of Spanish and Italian dogs [11-14]. However,
evidence that natural R. conorii infection causes illness
in dogs remains limited. Illness has been associated with
R. conorii natural infection in only a few dogs since
human MSF was described in 1910 [15]. The possibility
that R. conorii may cause a clinical disease in dogs is
supported by the evidence of seroconversion in three
sick dogs from Israel [16] and the association between
anemia and seroreactivity to R. conorii antigens [17]. In
addition, a study reported the association between male
dogs and seroreactivity to R. conorii antigens as found in
humans where males have higher rates of infection [2,17].
Moreover, febrile illness has been associated with R. con-
orii infection in three dogs from Sicily by means of sero-
conversion and PCR [13] and in seven dogs from Portugal
by PCR [18]. For this reason, the clinical significance of
infection with R. conorii, or other SFG rickettsiae in dogs,
remains unclear and requires further characterization.
The aims of this prospective case–control study were:
1) to investigate the presence of Rickettsia spp. infection
in dogs from southern Italy (Sicily and Reggio Calabria)
with fever by means of serological and molecular tests
when compared with case control dogs with normalbody temperatures; 2) to evaluate whether Rickettsia spp.
infection causes clinical disease and clinicopathological
abnormalities by clinical history, physical examination and
baseline laboratory tests; and 3) to evaluate co-infections
with other microorganisms that cause canine vector borne
diseases such as Leishmania infantum, Ehrlichia spp.,
Anaplasma spp., Babesia spp. and Hepatozoon canis and
their clinical importance in sick dogs.
Methods
Dogs
The study was carried out between August-November
2009 and between April-November 2010 in Sicily, Italy.
Dogs were enrolled in the study from 20 Veterinary
clinics throughout Sicily (Catania, Caltanissetta, Enna,
Messina, Palermo, Siracusa and Trapani) and from the
south of Calabria (Reggio Calabria).
Physical and laboratory examinations were performed
during the study at the time of onset of clinical signs
and after one month or later. MSF is most commonly
described in humans with a maximum peak in June and
August [2]. Clinical questionnaires were distributed and
filled by veterinarians to obtain detailed clinical data at
the time of onset of clinical signs and after one month
or later. Information collected from the questionnaires
included the date of sample collection, age, sex, breed,
type of housing (indoor versus outdoor), flea and tick
exposure, presence of vectors on clinical examination,
vaccination status, presenting complaint, clinical signs
observed, previous medical history, clinical response to
specific therapy and clinical status of the dog’s owner.
Blood serum samples were taken two times (first and
second visit) when possible with an interval between
samplings of one month in the majority of dogs or two
months in few dogs, in order to evaluate acute (first
visit) and convalescent (second visit) antibodies and
seroconversion. Blood was taken in EDTA tubes at the
time of diagnosis prior to doxycycline treatment and
after one month or more. One hundred and seventy-one
dogs were included in the study and they were divided
into two groups: febrile dogs and afebrile dogs.
Febrile dogs
Ninety-nine dogs with febrile illness were enrolled in the
study. The inclusion criteria were: 1) Dogs with an acute
onset (less than 10 days of duration) of fever (≥39.5°C)
were included. 2) Only dogs with informed consent
signed by the owner were enrolled. The exclusion cri-
teria were: 1) Dogs with an acute onset of fever and evi-
dence of another disease involved such as heat-stroke,
neoplasia, bacterial abscesses and pyometra; 2) Dogs
with a recent history of doxycycline administration
during the past two months; 3) Dogs without signed
informed consent by the owner.
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A case control set of dogs (n = 72) with no apparent disease
or other diseases unrelated to febrile illness was randomly
selected from dogs seen at the same veterinary clinics dur-
ing the same month as the febrile dogs. The inclusion cri-
teria were: 1) Healthy dogs evaluated for routine procedures
such as vaccinations, elective surgery (neutering/spaying); 2)
Sick dogs that did not present with acute fever (≥39.5°C) or
suspicion of tick-transmitted disease; 3) Only dogs with
informed consent signed by the owner were enrolled in the
study. The exclusion criteria were: 1) Dogs recently treated
with doxycycline during the last two months; 2) Dogs
without signed informed consent by the owner.
Only privately owned dogs were included in the study
and examined by routine non-invasive diagnostic proce-
dures. Owners were accurately informed and an informed
consent was signed by both owner and veterinarian. Eight
dogs presented clinical signs but not fever.
Blood samples from dogs were taken for diagnostic
purposes as part of clinical management and, therefore,
no ethical approval was needed.
Unfortunately, only 92 out of 171 dogs enrolled in the
study came back for a second visit a month or more after
the first visit.
Laboratory procedures
Routine laboratory tests
Complete blood count (CBC) with blood smear examin-
ation and platelet concentration, complete biochemical
profile including C-reactive protein and serum electro-
phoresis were performed in all dogs at the time of diagno-
sis and second visit as previously described [19]. The
samples were submitted in less than 24 hours from blood
withdrawal to Laboratorio Privato di Analisi Veterinarie
San Marco (Padua, Italy). Whole EDTA blood and serum
samples for PCR and serology were stored at −20°C until
used for molecular and serological testing.
Serological techniques (IFA or ELISA)
Indirect immunofluorescence assays (IFA) kits from
Fuller Laboratories (Fullerton, CA, USA) were used for
IgG antibodies detection against R. conorii, E. canis and
A. phagocytophilum antigens following manufacturer’s
instructions.
IFA does not distinguish between canine antibodies
against A. phagocytophilum and Anaplasma platys [20]. In
addition, the IFA test used for Rickettsia conorii is known
to cross-react with other species of spotted fever group
Rickettsia such as R. rickettsii, R. helvetica, R. slovaca and
R. massiliae as stated in manufacturer’s instructions.
An antibody titer of 1:64 or greater was considered
positive for R. conorii antigen. An antibody titer of 1:80
or greater was considered positive for E. canis and A.
phagocytophilum antigens.Seroconversion was defined as ≥ 2–4 fold increase con-
valescent antibody titers (second visit) when acute (first
initial visit) titers were positive or as any positive antibody
titers when acute (first initial visit) titers were negative.
High antibody titers were defined as equal or greater of
1:512 (R. conorii) or 1:640 (E. canis and A. phagocytophi-
lum). Paired samples were run the same day.
ELISA was performed to detect antibodies against
L. infantum as previously described [21].
DNA extraction, real-time PCR for Rickettsia spp. and other
infectious agents and DNA sequencing
DNA extraction was performed from EDTA-
anticoagulated whole blood sample by the High Pure
PCR Template Preparation Kit (Roche Applied Science,
GmbH, Mannheim, Germany) in accordance with the
manufacturer’s protocol with some modifications. Two
hundred μL of blood were incubated with 40 μL of
Proteinase K and with 200 μL of Binding Buffer at 72°C
for 1 h. Subsequent steps were carried out according to
the manufacturer’s instructions (Roche Applied Science,
GmbH, Mannheim, Germany). DNA was eluted in
50 μL of elution buffer at 72°C [13].
A quantitative PCR (qPCR) for the detection of Rickettsia
spp., A. phagocytophilum/A. platys, E. canis and L.
infantum in DNA samples was performed. PCR amplifi-
cations were carried out for Rickettsia spp. [13,14], E.
canis, A. phagocytophilum/A. platys (fragment of 16S
rRNA gene) [22], and L. infantum (fragment of kineto-
plast minicircle) [23] using LCSet primers and probes
following manufacturer’s instructions (TIB MOLBIOL).
Real-time PCR amplifications were carried out in Roche
LightCycler, version 3.5.17, (Roche Diagnostic, GmbH,
Mannheim, Germany), with a final volume of 10 μL, in-
cluding 2.5 μL of the DNA template, 2 μL of Light Cycler
Fast start reaction mix (FastStart DNA MasterPLUS, Roche
Diagnostic, GmbH, Mannheim, Germany), and 0.5 μL of
LCSet primers and probes according to the manufacturer’s
instructions (TIB Molbiol, Berlin, Germany). Amplifica-
tions were conducted in sealed 20 μL Light Cycler
glass capillaries (Roche Diagnostic, GmbH, Mannheim,
Germany). Thermal cycling for Rickettsia spp qPCR com-
prised an initial denaturation step at 95°C for 8 min,
followed by 55 cycles of a denaturation at 95°C for 5 s, an-
nealing at 59°C for 7 s, and extension at 72°C for 7 s, with
quantification of fluorescence signal [13,14]. Thermal cyc-
ling for A. phagocytophilum/A. platys qPCR comprised an
initial denaturation step at 95°C for 8 min, followed by
45 cycles of a denaturation at 95°C for 5 s, annealing at
61°C for 10 s, and extension at 72°C for 11 s, with quanti-
fication of fluorescence signal [22]. Thermal cycling for E.
canis qPCR comprised an initial denaturation step at 95°C
for 8 min, followed by 60 cycles of a denaturation at 95°C
for 5 s, annealing at 61°C for 10 s, and extension at 72°C
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Thermal cycling for Leishmania infantum qPCR com-
prised an initial denaturation step at 37°C for 10 min, 95°
C for 8 min, followed by 45 cycles of a denaturation at 95°
C for 5 s, annealing at 60°C for 5 s, and extension at 72°C
for 4 s, with quantification of fluorescence signal [23]. A
real-time PCR reaction was considered positive when the
normalized fluorescence signal [ratio of the signal from
detection channel F2 (640 nm) to the signal from detec-
tion channel F1 (495 nm) at the end of the annealing step]
showed an exponential increase in fluorescence. The
melting temperature of probe–template hybrids was
automatically determined by the analysis of the software,
and was useful for species identification of Rickettsia
rickettsii versus other Rickettsia species and A. phagocyto-
philum versus A. platys. Rickettsia rickettsii had a melting
temperature of approximately 65°C, while R. conorii had a
melting temperature of approximately 58.2°C. Anaplasma
phagocytophilum had a melting temperature of approxi-
mately 66°C, while A. platys had a melting temperature of
approximately 57°C. Each real-time PCR run include a
blank, a negative control, and a DNA cloned amplicon as
a positive control (LCSet positive control; TIB Molbiol,
Berlin, Germany).
Conventional PCRs for the detection of fragment of
18S rRNA gene of Babesia spp. [24] and of 18S rRNA
gene of Hepatozoon spp. [25] were also carried out, as
previously described. The partial 18S rRNA gene for
Babesia spp. was amplified by using conventional PCR
analysis in a final volume of 50 μL, containing 2.5 μL of
DNA template from each sample, 1 μL (10 pmol/ μl) of each
of the primers, PIRO-A and PIRO-B, 1 μL (10 pmol/μl)
of deoxyribonucleotide triphosphates (dNTPs) (Roche
Diagnostics, GmbH, Mannheim, Germany), 5 μL of PCR
buffer 10X (5 PRIME GmbH, Hamburg, Germany), and
1U of recombinant Taq DNA polymerase (5 PRIME
GmbH, Hamburg, Germany). DNA amplification was per-
formed with the Thermal Cycler 2720 (Applied Biosystems,
Europe) at the following temperature profiles: initial
denaturation at 95°C for 5 minutes, denaturation at 95°C
for 30 seconds, annealing at 58°C for 30 seconds, extension
at 72°C for 30 seconds, and repeated for 35 cycles, with a
final extension for 7 minutes at 72°C. The partial 18S
rRNA gene (666 bp) for Hepatozoon canis was amplified
by using conventional PCR analysis in a final volume of
50 μL, containing 5 μL of DNA template from each
sample, 1 μL (10 pmol/μl) of each of the primers, HEP-F
and HEP-R, 1 μL (10 pmol/μl) of dNTPs (Roche Diagnos-
tics, GmbH, Mannheim, Germany), 5 μL of PCR buffer
10X (5 PRIME GmbH, Hamburg, Germany), and 1 U of
recombinant Taq DNA polymerase (5 PRIME GmbH,
Hamburg, Germany). DNA amplification was performed
with the Thermal Cycler 2720 (Applied Biosystems, Europe)
at the following temperature profiles: initial denaturation at95°C for 5 minutes, denaturation at 95°C for 30 seconds,
annealing at 53°C for 30 seconds, extension at 72°C for
30 seconds, and repeated for 35 cycles, with a final exten-
sion for 7 minutes at 72°C.
DNA electrophoresis for amplicons detection was
carried out in 2.2% FlashGel System (Lonza, Rockland,
ME USA), and DNA fragments were visualized. For sub-
sequent sequencing of Babesia spp. and Hepatozoon spp.
positive samples, amplification product from PCR was
submitted for direct sequencing.
Rickettsia positive samples by qPCR for 16S gene were
also amplified for the OmpA gene by a conventional PCR
for further molecular characterization [13,14]. The partial
OmpA gene for Rickettsia spp was amplified by PCR in a
final volume of 50 μL, containing 5 μL of DNA template
from each sample, 1 μL (10 pmol/μl) of each of the
primers, 107F and 299R 1 μL (10 pmol/μl) of dNTPs
(Roche Diagnostics, GmbH, Mannheim, Germany), 5 μL
of PCR buffer 10X (5 PRIME GmbH, Hamburg,
Germany), and 1U of recombinant Taq DNA polymerase
(5 PRIME GmbH, Hamburg, Germany). DNA amplifica-
tion was performed with the Thermal Cycler 2720 (Applied
Biosystems, Europe) at the following temperature profiles:
initial denaturation at 95°C for 5 minutes, denaturation at
95°C for 30 seconds, annealing at 54°C for 30 seconds,
extension at 72°C for 30 seconds, and repeated for
35 cycles, with a final extension for 7 minutes at 72°C.
The samples were sequenced and compared to known
sequences deposited in GenBank®. The sequencing reaction
was performed with the Applied Biosystem 3730xI DNA
Analyzer on both strands by BMR Genomics srl (Padua,
Italy) by using the dideoxychain-termination method [26].
Consensus sequences were aligned [(BIOEDIT version
7.0 (ClustalW)] with known sequences in GenBank®
using the basic local alignment search tool (BLAST) avail-
able from (http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=
blastn&PAGE_TYPE=BlastSearch&LINK_LOC=blasthome).
Sequences were deposited in GenBank®.
Current Rickettsia infection was considered when dogs
were positive to Rickettsia PCR and/or demonstrated
seroconversion to R. conorii antigen.
Statistical analysis
For univariate analysis, Chi-square and Fisher’s exact tests
were used to test for associations between proportions and
putative explanatory factors and univariate Odds ratios
(OR) were calculated. The differences were considered sig-
nificant if the P-value was <0.05. SPSS (IBM, USA) statis-
tical software (version 19) was used for statistical analyses.
Results
Dogs
The dog population characteristics including breed, gen-
der, age and presence or absence of ticks per each group
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found between breed and presence or absence of ticks and
febrile versus afebrile group (Table 1).Serological and PCR results for all pathogens
The serological results in febrile and afebrile dogs at the
time of the first and second visits are shown in Table 2.
The total first visit seropositivity rates for R. conorii, E.
canis, A. phagocytophilum and L. infantum were 44.8%,
48.5%, 37.8% and 17.6%, respectively. The seroconversion
results for R. conorii, E. canis and A. phagocytophilum
antigens in both groups of dogs are displayed in Table 3.
The total seroconversion rates for R. conorii, E. canis and
A. phagocytophilum were 20.7%, 14.3% and 8.8%, respect-
ively. Seroconversion rates for R. conorii were significantly
higher in febrile dogs when compared with afebrile dogs
(Chi-square = 4.070, P = 0.0436). The seroconversion rates
for E. canis and A. phagocytophilum were not different
among the groups studied (Table 3).
The total first visit molecular positive rates for Rickettsia
spp., E. canis, A. phagocytophilum, A. platys, L. infantum,
Babesia spp. and Hepatozoon spp. were 1.8%, 4.1%, 0%,
2.3%, 11.1%, 2.3% and 0.6%, respectively. Positive PCR for
E. canis (7.1%), Rickettsia spp. (3%), Babesia spp. (4%) and
Hepatozoon spp. (1%) were only found in febrile dogs
(Table 4).
Fourteen febrile dogs (31.8%) were diagnosed with
Rickettsia spp. infection based on seroconversion and/
or PCR while only six afebrile dogs (12.5%) serocon-
verted (Chi-square = 5.036; P = 0.0248; Fisher’s exact
test; P = 0.0414).
Febrile illness was statistically significant associated
with: acute R conorii positive antibody reaction (Chi-
square = 10.837; univariate Odds ratio = 2.944; P = 0.001);
convalescent R. conorii positive antibody reaction (Chi-
square = 7.312; univariate Odds ratio = 4.253; P = 0.001);
seroconversion to R. conorii (Chi- square = 4.070; univariate
Odds ratio = 2.935; P= 0.044); E. canis positive PCR (Chi-
square = 5.236; univariate Odds ratio = 1.247; P calculated
with Fisher’s exact test = 0.042); E. canis or Rickettsia or
Anaplasma PCRs positive (Chi-square = 6.835; univariate
Odds ratio = 9.793; P = 0.009); positivity to any tick pathogenTable 1 Description of dog population characteristics
DOGS BREED GENDER
N = 159 N = 171
Mixed Pure Male Female
Total 58/159 (37.1%) 101/159 (63.5%) 94/171 (54.9%) 77/171 (45
Febrile 40/58** (68.9%) 53/101 (52.4%) 40/94 (42.5%) 45/77 (58.4
Afebrile 18/58 (31%) 48/101 (47.5%) 54/94 (57.4%) 32/77 (42.8
*For age classification, young was considered as less than 12 months of age and ad
***Chi-square = 17.622, P < 0.0001.PCRs (Chi-square = 10.161; univariate odds ratio = 13.687;
P= 0.001).
Twelve febrile dogs (12.6%) displayed initial high R. conorii
antibody titers while only five afebrile dogs (7.1%) presented
initial high R. conorii antibody titers (Chi-square = 1.314;
P= 0.252). Eleven febrile dogs (25%) displayed convalescent
high R. conorii antibody titers while only 4 afebrile dogs
(8.3%) presented convalescent high R. conorii antibody titers
(Chi-square = 2.860; P= 0.091).
Five febrile dogs (35.7%) displayed initial high E. canis
antibody titers while none the afebrile dogs (0.0%) presented
initial high E. canis antibody titers (Chi-square = 3.840;
P = 0.050). Five out of seven febrile dogs (71.4%) diag-
nosed with E. canis infection by means of PCR were sero-
negative (n = 2) or presented a low positive antibody titer
(1:80; n = 3) at the time of illness and seroconverted sug-
gesting acute infection. Only two febrile dogs diagnosed
by positive E. canis PCR presented an initial high antibody
titer (1:1280).
Three out of three febrile dogs (100%) diagnosed with
A. platys infection by means of PCR were seronegative
or presented a low positive antibody titer (1:80) by A.
phagocytophilum IFA at the time of illness and only one
seroconverted suggesting acute infection. Only one fe-
brile dog diagnosed by positive A. platys PCR presented
high antibody titer (1:1280).
Initial E. canis IFA was statistically associated with A.
phagocytophilum IFA (Chi-square = 93.490; P < 0.0001).
Co-infections
Seven febrile dogs diagnosed with Rickettsia spp. infection
based on seroconversion and/or PCR presented coinfections
with A. platys diagnosed by PCR (n = 2), or with E. canis di-
agnosed by seroconversion (n = 1) or with both E. canis and
A. phagocytophilum diagnosed by seroconversion (n = 2) or
with Babesia diagnosed by PCR (n = 2). Two afebrile dogs
diagnosed with Rickettsia spp infection based on serocon-
version presented coinfections with E. canis diagnosed by
seroconversion (n = 1) and with both E. canis and A. phago-
cytophilum diagnosed by seroconversion (n = 1).
Only febrile dogs presented coinfections with more
than one pathogen demonstrated by molecular analysis:
one coinfected with R. conorii and A. platys, one with E.AGE* TICKS
n = 161 N = 121
Young Adult Presence Absence
%) 16/161 (9.9%) 145/161 (90%) 31/121 (25.6%) 90/121 (74.3)
%) 13/16 (81.2%) 85/145 (58.6%) 29/31*** (93.5%) 46/90 (51.1%)
%) 3/16 (18.7%) 60/145 (41.3%) 2/31 (6.4%) 44/90 (48.8%)
ult was considered as above 12 months of age **Chi-square = 4.126, P = 0.042
Table 2 Seroreactivity to several tick-borne pathogens antigens in febrile and afebrile dogs at the time of first and
second visit
Pathogens Initial serology (first visit) Convalescent serology (second visit)
Febrile Afebrile Total Febrile Afebrile Total
N=95 N=70 N=165 N=44 N=48 N=92
R. conorii 53 (55.8%)* 21 (30.0%) 74 (44.8%) 29 (65.9%)** 15 (31.2%) 44 (47.8%)
E. canis 47 (50.0%) 32 (46.4%) 79 (48.5%) 15 (34.1%) 11 (22.9%) 26 (28.2%)
A. phagocytophilum 38 (40.4%) 24 (34.3%) 62 (37.8%) 9 (20.4%) 7 (14.6%) 16 (17.4%)
L. infantum*** 20 (20.2%) 10 (14.1%) 30 (17.6%) Not determined
*Chi-square = 10.837, P = 0.001;**Chi-square = 11.052, P = 0.002; *** Number of febrile dogs was 99; Number of afebrile dogs was 71; total number of dogs was 170.
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one with L. infantum and A. platys and two coinfected
with L. infantum and B. vogeli.
Clinical manifestations and clinicopathological
abnormalities
The most common clinical signs and laboratory abnormal-
ities of febrile dogs diagnosed with Rickettsia infection based
on seroconversion and/or PCR were fever, lethargy, myalgia,
lameness, elevation of C-reactive protein, hypoalbuminemia,
thrombocytopenia and mild non-regenerative anemia. How-
ever, other less common clinical signs and clinicopathologi-
cal abnormalities included orchitis, lymphadenomegaly,
splenomegaly, abdominal pain/hunched posture, vomiting
and diarrhea, hyperglobulinemia, elevation liver enzymes
(ALP, AST) and mature neutrophilic leukocytosis.
Anemia was statistically associated with the presence of
an initial high R. conorii antibody titer (Chi-square = 3.877;
P = 0.049), positive serology for L. infantum (Chi-square =
4.229; P = 0.040), positive E. canis PCR (Fisher’s exact
test; P = 0.048), with positivity for E. canis or Rickettsia
or Anaplasma PCR (Chi-square = 4.229; P = 0.040) and
with positivity for any of the pathogens studied by PCR
(Chi-square = 4.561; P = 0.033). Thrombocytopenia was
statistically associated with the presence of positive con-
valescent R. conorii antibody titer (Chi-square = 4.227;
P = 0.040), with acute high E. canis antibody titer
(Chi-square = 10.809; P = 0.001), with positive convalescent
E. canis antibody titer (Chi-square = 4.463; P = 0.035). It
was also significantly associated with positive acute A. pha-
gocytophilum antibody titer (Fisher’s exact test; P = 0.005),
with high convalescent A. phagocytophilum antibody titersTable 3 Seroconversion results for R. conorii, E. canis, A. phag
Pathogens Seroconversion
Number of positive dogs (%
Febrile
N = 44
R. conorii 13 (29.5%, 18-44%)*
E. canis** 7 (16.3%, 7-29%)
A. phagocytophilum** 3 (7.0%, 1-18%)
*Chi-square = 4.070, P = 0.0436;**Number of febrile dogs was 43; number of total do(Fisher’s exact test; P= 0.037), with E. canis positive PCR
(Fisher’s exact test; P= 0.002), with positivity for E. canis or
Rickettsia or Anaplasma PCR (Chi-square = 9.888; P= 0.002)
and with positivity for any of the pathogens studied by
PCR (Chi-square = 14.457; P <0.0001). Hemoparasites
were not found by blood smear examination in any of the
dogs included in the study.
DNA sequences
The OmpA gene DNA sequences (170 bp) obtained
from three Rickettsia positive PCR samples (GenBank®
accession numbers KP896303, KP896304 and KP896305)
were 100% identical to several R. conorii sequences
present in GenBank® (e.g.: GenBank® accession number
KJ433804 and KF245453). The above OmpA gene DNA
sequences were only 95% identical to the R. parkeri
sequences present in GenBank® (GenBank® accession
number: KJ158741, KJ174528, JQ906784) which were the
second BLAST match.
The 18SrRNA gene DNA sequence (412 bp) obtained
from four Babesia spp. positive PCR samples (GenBank®
accession numbers KP896299, KP896300, KP896301 and
KP896302) were 100% identical to the B. vogeli sequences
present in GenBank® (GenBank® accession number:
HQ148663). The positive amplicon for Hepatozoon spp.
PCR was not sequenced due to the low amount of DNA
in the sample.
Discussion
This study demonstrates acute febrile illness associated
with natural Rickettsia infection in dogs living in en-
demic areas of human MSF by means of seroconversionocytophilum in febrile and afebrile dogs
, CI 95%)
Afebrile Total
N = 48 N = 92
6 (12.5%, 5-25%) 19 (20.7%, 13-30%)
6 (12.5%, 5-25%) 13 (14.3%, 8-22%)
5 (10.4%, 4-22%) 8 (8.8%, 4-16%)
gs was 91.
Table 4 Molecular prevalence of all pathogens in febrile
and afebrile dogs at the first visit
Pathogens PCR
Febrile Afebrile Total
n = 99 n = 71 n = 170
R. conorii 3 (3.0%)* 0 (0%) 3 (1.8%)
E. canis 7 (7.1%)** 0 (0%) 7 (4.1%)
A. platys 3 (3.0%) 1 (1.4%) 4 (2.3%)
B. vogeli 4 (4.0%) 0 (0%) 4 (2.3%)
H. canis 1 (1.0%) 0 (0%) 1 (0.6%)
L. infantum 14 (14.1%) 5 (6.9%) 19 (11.1%)
*All dogs were positive to 16SrRNA and OmpA PCRs; ** Fisher’s exact
test, P = 0.042
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PCR in comparison to an afebrile control group. Since
human MSF was first described in 1910 by Conor and
Bunch, canine illness associated with naturally occur-
ring R. conorii infection has been described in only a
few dogs. Rickettsia conorii infection associated with fe-
brile illness was described in three dogs from Sicily by
means of seroconversion and PCR [13] and seven dogs
from Portugal by serology and PCR [18]. In addition,
this study found significantly higher acute and conva-
lescent R. conorii antibody titers in febrile dogs when
compared with afebrile-control dogs.
Spotted fever group Rickettsia infection have so far
only been recognized as causing acute infections in
humans and dogs [1,27]. Therefore, acute and convales-
cent antibodies and PCR at the time of diagnosis were
employed as diagnostic tools in this study to allow the
detection of canine Rickettsia spp. infection. Interest-
ingly, the majority of febrile dogs were diagnosed based
on seroconversion to Rickettsia antigen and only three
febrile dogs were diagnosed by molecular analysis in
agreement with human MSF diagnostic findings [1,28,29].
Molecular detection of Rickettsia spp. such as R. conorii in
blood appears to be of low to moderate sensitivity in humans
[1,29,30] and in dogs [14] as found also in this study. The
discrepancy between serological and molecular testing is
likely due to the fact that Rickettsia spp. circulate in blood in
low numbers during the acute phase of infection [2,31] and
are probably rapidly cleared from blood. Accordingly, experi-
mental infections of dogs with R. conorii resulted in a short
rickettsiemia of 2–10 days post-infection [6,7] which did not
recur following immunosuppression [15].
Clinical signs and clinicopathological abnormalities
detected in febrile dogs diagnosed with Rickettsia spp.
infection based on seroconversion or positive PCR at ini-
tial examination were similar to abnormalities associated
with SFG rickettsiosis in humans [2,3,32,33] and Rocky
Mountain Spotted Fever rickettsiosis in dogs [34,35] andin experimental infections of dogs with R. conorii [6,7].
The majority of experimentally R. conorii infected dogs
presented acute fever, anorexia and lethargy [6,7]. In
addition, similar clinical signs and clinicopathological ab-
normalities were detected in three client-owned Yorkshire
terriers living in Sicily [13] and in seven client-owned
Portuguese dogs [18].
Due to the fact that the majority of febrile dogs with
Rickettsia spp. infection were diagnosed by seroconver-
sion and the detection of rickettsiemia was not success-
ful by molecular techniques in the majority of dogs, the
Rickettsia species infecting the majority of these dogs
remains unclear. It is well known that serological cross-
reaction exists between different species of Rickettsia
[28] and, therefore, R. conorii might not be the only
pathogen infecting these dogs. However, based on
current knowledge, the most likely species infecting dogs
is R. conorii due to the fact that, so far, only R. conorii
has been diagnosed by molecular techniques in the
Mediterranean region [13,18] in dogs. In addition, the
most common Rickettsia pathogen recognized in Sicily
in humans and ticks is R. conorii [36] including different
strains [4,5]. Other Rickettsia species such as R. slovaca
[5], R. africae, R. aeschlimannii [37] and a new spotted
fever group Rickettsia [38] have been occasionally found
in Sicily in ticks and R. massiliae has been isolated from
one human patient [39]. Additionally, three febrile dogs
from the present study were diagnosed by DNA amplifi-
cation and sequencing of R. conorii as the most likely
infecting pathogen. Moreover, the three previous canine
rickettsiosis cases reported in Sicily were diagnosed as R.
conorii infection as well [13]. However, the pathogenic
role of R. massiliae might be more important than previ-
ously thought and this rickettsia might cause MSF in
humans [39-41] and subclinical [6] or febrile illness in
dogs [42]. This is due to the facts that a moderate pro-
portion of Rh. sanguineus ticks are infected with this
microorganism [42-46], human cases of this infection
have occasionally been reported [39-41] and R. massiliae
antibodies are present in dogs [42,47] and humans
[48,49]. Further studies should try to improve diagnostic
techniques to better characterize the species of Rickettsia
infecting dogs in Sicily and in the Mediterranean basin.
The findings of Rickettsia seroconversion in afebrile
control dogs including healthy dogs suggest that, in some
dogs, Rickettsia infection is subclinical. This finding is in
agreement with experimental infections [6,7] and previous
literature where dogs have been considered only sentinels
of this infection [50,51]. Clinical manifestations of R. con-
orii or Rickettsia spp. infections can vary from subclinical
to commonly mild disease in humans and other mammals
including dogs, as demonstrated in the present study [2].
Serological and molecular positive rates obtained for
E. canis, A. phagocytophilum, A. platys, B. vogeli and L.
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southern Italy [52,53] and other Mediterranean areas
[54]. In contrast, there is insufficient information on
seroconversion of tick-transmitted pathogens in sick and
healthy dogs in endemic areas. Interestingly, higher
seroconversions were found with R. conorii than with
E. canis and A. phagocytophilum and R. conorii sero-
conversion was the only infection significantly associated
with febrile illness in this study.
In the present study, febrile illness was associated with
several tick pathogens and detection of DNA of patho-
gens was mainly observed in febrile dogs. In addition,
coinfections were only detected by molecular techniques
in dogs with febrile illness. The pathogenic role of coin-
fections remains unclear and is scarcely investigated
[55,56]. However, the findings of this study suggest that
coinfections diagnosed by PCR demonstrating active in-
fection might aggravate clinical manifestations as previ-
ously reported [55,57].
In this study, the majority of febrile cases were diag-
nosed as associated with acute E. canis infection based on
PCR-positive and acute negative or low positive antibody
titers and evidence of seroconversion. Interestingly, it is
thought that the majority of clinical cases of E. canis infec-
tion correspond to the chronic phase of this disease
[58-60] while, in our study, clinical signs and laboratory
abnormalities were mainly found during acute infections.
The association of antibody reactivity found between E.
canis and A. phagocytophilum is not surprising due to the
well-known cross-reaction that occurs between Ehrlichia
and Anaplasma species [60]. In the present study, we
consider that the A. phagocytophilum positive serological
results are most likely due to A. platys infection in dogs
rather than a true infection with A. phagocytophilum due
to the fact that only A. platys was diagnosed by molecular
techniques and the location of tested dogs in Sicily where
only A. platys is prevalent in dogs [61].
There is limited clinical knowledge about B. vogeli infec-
tion in dogs in endemic areas. Babesia vogeli infection is
considered to cause subclinical infection or a mild to mod-
erate diseases in some dogs [24,62,63]. Surprisingly, in the
present study, B. vogeli infection was only detected in fe-
brile dogs while subclinical infection was not evident based
on molecular analysis in this study. Unfortunately, Babesia
serology and seroconversion were not performed as this
could have decreased the number of truly infected dogs
diagnosed in this study. Although blood molecular analysis
is probably the most sensitive and accurate diagnostic
technique for active Babesia infection in dogs [62], it is
important to highlight that Babesia parasites were not ob-
served on blood smear examination. Based on the present
findings, B. vogeli should be included in the differential
diagnosis of dogs with febrile illness and blood PCR appears
to be the best diagnostic technique to use for its detection.Hepatozoon canis infections in dogs are frequently
subclinical in endemic areas and clinical cases are spor-
adically reported [64]. Interestingly, in the present study,
only one young febrile dog was diagnosed with H. canis
infection. These findings are unusual due to the fact that
higher rates of H. canis infection are reported in Medi-
terranean endemic areas [54,64,65] and that subclinical
infections were not found. In addition, the dog with
hepatozoonosis was coinfected with an acute E. canis in-
fection diagnosed by PCR. Unfortunately, the dog was
lost during follow-up and clinical data about response to
treatment was lacking. Whether the clinical signs and
clinicopathological abnormalities observed were attrib-
uted only to E. canis infection or to both infections
remains unclear and further studies would need to eluci-
date the role of coinfections and H. canis in febrile
illness in endemic areas.
Conclusions
In conclusion, this study demonstrates acute febrile ill-
ness associated with natural Rickettsia infection in dogs
living in MSF endemic areas based on acute and conva-
lescent antibody titers, seroconversion alone and the
combination of seroconversion and PCR. The most com-
mon clinical signs and clinicopathological abnormalities
were similar to those described in human and canine
spotted fever rickettsiosis. Additional febrile illness was
associated with E. canis infection demonstrated by PCR,
and with detection of tick pathogens and co-infection
demonstrated by molecular techniques.
Abbreviations
DNA: Deoxyribonucleic acid; IFA: Immunofluorescence antibody assay;
qPCR: Quantitative PCR; MSF: Mediterranean Spotted fever; PCR: Polymerase
chain reaction; SFG: Spotted fever group.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LSG and MGP designed the research study. LSG set up ELISA and IFAs,
contributed with data analysis and interpretation and wrote the manuscript.
AC coordinated the veterinary clinics enrolled, set up and performed ELISAs
and IFAs, contributed with data analysis and interpretation and revised the
manuscript. MGP contributed with data analysis and interpretation and
revised the manuscript. MC and TF contributed with routine laboratory
testing and revised the manuscript. MT performed DNA extraction, real-time
PCR and conventional PCR and revised the manuscript. All authors read and
approved the final version of the manuscript.
Acknowledgments
The authors thank all veterinarians and dog owners that contributed to this
study. The authors thank also Martina Nicetto for her help on molecular
analysis and the staff of Laboratorio Privato di Analisi Veterinarie San Marco
(Padua, Italy) for their support to this study. We are grateful to Dr Ruby
Chang (Royal Veterinary College) for assistance with statistical analyses.
The authors are also grateful to Bayer Animal Health (Germany) and Bayer
Italia S.p.A. and Laboratorio Privato di Analisi Veterinarie San Marco (Padua,
Italy) for funding this study. Publication fees of this manuscript have been
sponsored by Bayer HealthCare - Animal Health division.
Solano-Gallego et al. Parasites & Vectors  (2015) 8:216 Page 9 of 10Dr. Laia Solano-Gallego hold a Ramón y Cajal senior researcher contract
awarded by the Ministerio de Ciencia e Innovación (Spain) and the European
Social Fund.
Author details
1Departament de Medicina i Cirurgia Animals, Facultat de Veterinària,
Universitat Autònoma de Barcelona (UAB), Cerdanyola 08193, Barcelona,
Spain. 2Royal Veterinary College, University of London, Hatfield, United
Kingdom. 3Clinica Veterinaria Camagna, Reggio, Calabria, Italy. 4Dip.to di
Scienze Veterinarie, Polo Universitario Annunziata, Messina, Italy. 5Laboratorio
Veterinario San Marco, Padova, Italy.
Received: 2 February 2015 Accepted: 23 March 2015References
1. Brouqui P, Parola P, Fournier PE, Raoult D. Spotted fever rickettsioses in
southern and eastern Europe. FEMS Immunol Med Microbiol. 2007;49(1):2–12.
2. Parola P, Paddock CD, Raoult D. Tick-borne rickettsioses around the world:
emerging diseases challenging old concepts. Clin Microbiol Rev.
2005;18(4):719–56.
3. Cascio A, Iaria C. Epidemiology and clinical features of Mediterranean
spotted fever in Italy. Parassitol. 2006;48(1–2):131–3.
4. Giammanco GM, Vitale G, Mansueto S, Capra G, Caleca MP, Ammatuna P.
Presence of Rickettsia conorii subsp. israelensis, the causative agent of Israeli
spotted fever, in Sicily, Italy, ascertained in a retrospective study. J Clin
Microbiol. 2005;43(12):6027–31.
5. Torina A, de Mera IG F, Alongi A, Mangold AJ, Blanda V, Scarlata F, et al.
Rickettsia conorii Indian tick typhus strain and R. slovaca in humans, Sicily.
Emerg Infect Dis. 2012;18(6):1008–10.
6. Levin ML, Zemtsova GE, Montgomery M, Killmaster LF. Effects of homologous
and heterologous immunization on the reservoir competence of domestic
dogs for Rickettsia conorii (israelensis). Ticks Tick-borne Dis. 2014;5(1):33–40.
7. Levin ML, Killmaster LF, Zemtsova GE. Domestic dogs (Canis familiaris) as
reservoir hosts for Rickettsia conorii. Vector Borne Zoonotic Dis. 2012;12(1):28–33.
8. Delgado S, Carmenes P. Canine seroprevalence of Rickettsia conorii infection
(Mediterranean spotted fever) in Castilla y Leon (northwest Spain). Eur J
Epidemiol. 1995;11(5):597–600.
9. Mannelli A, Mandola ML, Pedri P, Tripoli M, Nebbia P. Associations between
dogs that were serologically positive for Rickettsia conorii relative to the
residences of two human cases of Mediterranean spotted fever in Piemonte
(Italy). Prev Vet Med. 2003;60(1):13–26.
10. Torina A, Caracappa S. Dog tick-borne diseases in Sicily. Parassitol.
2006;48(1–2):145–7.
11. Estrada-Pena A, Venzal Bianchi JM. Efficacy of several anti-tick treatments to
prevent the transmission of Rickettsia conorii under natural conditions.
Ann New York Acad Sci. 2006;1078:506–8.
12. Torina A, Vicente J, Alongi A, Scimeca S, Turla R, Nicosia S, et al. Observed
prevalence of tick-borne pathogens in domestic animals in Sicily, Italy during
2003–2005. Zoonoses Public Health. 2007;54(1):8–15.
13. Solano-Gallego L, Kidd L, Trotta M, Di Marco M, Caldin M, Furlanello T, et al.
Febrile illness associated with Rickettsia conorii infection in dogs from Sicily.
Emerg Infect Dis. 2006;12(12):1985–8.
14. Solano-Gallego L, Trotta M, Caldin M, Furlanello T. Molecular survey of Rickettsia
spp. in sick dogs in Italy. Zoonoses Public Health. 2008;55(8–10):521–5.
15. Kelly PJ, Matthewman LA, Mason PR, Courtney S, Katsande C, Rukwava J.
Experimental infection of dogs with a Zimbabwean strain of Rickettsia
conorii. J Trop Med Hyg. 1992;95(5):322–6.
16. Baneth G, Breitschwerdt EB, Hegarty BC, Pappalardo B, Ryan J. A survey of
tick-borne bacteria and protozoa in naturally exposed dogs from Israel.
Vet Parasitol. 1998;74(2–4):133–42.
17. Solano-Gallego L, Llull J, Osso M, Hegarty B, Breitschwerdt E. A serological
study of exposure to arthropod-borne pathogens in dogs from northeastern
Spain. Vet Res. 2006;37(2):231–44.
18. Alexandre N, Santos AS, Bacellar F, Boinas FJ, Nuncio MS, de Sousa R.
Detection of Rickettsia conorii strains in Portuguese dogs (Canis familiaris).
Ticks Tick-borne dis. 2011;2(2):119–22.
19. Furlanello T, Fiorio F, Caldin M, Lubas G, Solano-Gallego L. Clinicopathological
findings in naturally occurring cases of babesiosis caused by large form Babesia
from dogs of northeastern Italy. Vet Parasitol. 2005;134(1–2):77–85.20. Stillman BA, Monn M, Liu J, Thatcher B, Foster P, Andrews B, et al. Performance
of a commercially available in-clinic ELISA for detection of antibodies against
Anaplasma phagocytophilum, Anaplasma platys, Borrelia burgdorferi, Ehrlichia
canis, and Ehrlichia ewingii and Dirofilaria immitis antigen in dogs. J Am Vet
Med Assoc. 2014;245(1):80–6.
21. Riera C, Valladares JE, Gallego M, Aisa MJ, Castillejo S, Fisa R, et al. Serological
and parasitological follow-up in dogs experimentally infected with Leishmania
infantum and treated with meglumine antimoniate. Vet Parasitol.
1999;84(1–2):33–47.
22. Solano-Gallego L, Trotta M, Razia L, Furlanello T, Caldin M. Molecular survey
of Ehrlichia canis and Anaplasma phagocytophilum from blood of dogs in
Italy. Ann N Y Acad Sci. 2006;1078:515–8.
23. Solano-Gallego L, Rodriguez-Cortes A, Trotta M, Zampieron C, Razia L, Furlanello T,
et al. Detection of Leishmania infantum DNA by fret-based real-time PCR in urine
from dogs with natural clinical leishmaniosis. Vet Parasitol.
2007;147(3–4):315–9.
24. Solano-Gallego L, Trotta M, Carli E, Carcy B, Caldin M, Furlanello T.
Babesia canis canis and Babesia canis vogeli clinicopathological findings
and DNA detection by means of PCR-RFLP in blood from Italian dogs
suspected of tick-borne disease. Vet Parasitol. 2008;157(3–4):211–21.
25. Inokuma H, Okuda M, Ohno K, Shimoda K, Onishi T. Analysis of the 18S
rRNA gene sequence of a Hepatozoon detected in two Japanese dogs.
Vet Parasitol. 2002;106(3):265–71.
26. Sanger E, Nicklen S, Coulson AR. DANN sequencing with chain terminating
inhibitors. Proc Natl Acad Sci U S A. 1977;74:5463–7.
27. Nicholson WL, Allen KE, McQuiston JH, Breitschwerdt EB, Little SE.
The increasing recognition of rickettsial pathogens in dogs and people.
Trends Parasitol. 2010;26(4):205–12.
28. Brouqui P, Bacellar F, Baranton G, Birtles RJ, Bjoersdorff A, Blanco JR, et al.
Guidelines for the diagnosis of tick-borne bacterial diseases in Europe.
Clin Microbiol Infect. 2004;10(12):1108–32.
29. Santibanez S, Portillo A, Santibanez P, Palomar AM, Oteo JA. Usefulness of
rickettsial PCR assays for the molecular diagnosis of human rickettsioses.
Enferm Infecc Microbiol Clin. 2013;31(5):283–8.
30. Znazen A, Sellami H, Elleuch E, Hattab Z, Ben Sassi L, Khrouf F, et al. Comparison
of two quantitative real time PCR assays for Rickettsia detection in patients from
Tunisia. PLoS Negl Trop Dis. 2015;9(2):e0003487.
31. Breitschwerdt EB, Levy MG, Davidson MG, Walker DH, Burgdorfer W, Curtis BC,
et al. Kinetics of IgM and IgG responses to experimental and naturally acquired
Rickettsia rickettsii infection in dogs. Am J Vet Res. 1990;51(8):1312–6.
32. Rovery C, Brouqui P, Raoult D. Questions on Mediterranean spotted fever a
century after its discovery. Emerg Infect Dis. 2008;14(9):1360–7.
33. Colomba C, Saporito L, Polara VF, Rubino R, Titone L. Mediterranean spotted
fever: clinical and laboratory characteristics of 415 Sicilian children.
BMC Infect Dis. 2006;6:60.
34. Ober CP, Spaulding K, Breitschwerdt EB, Malarkey DE, Hegarty BC. Orchitis in
two dogs with Rocky Mountain spotted fever. Vet Radiol Ultrasound.
2004;45(5):458–65.
35. Gasser AM, Birkenheuer AJ, Breitschwerdt EB. Canine rocky mountain
spotted fever: a retrospective study of 30 cases. J Am Anim Hosp Assoc.
2001;37(1):41–8.
36. Giammanco GM, Di Rosa S, Ammatuna P, Mansueto P, Micalizzi A, Vitale G.
Continous alert for rickettsiosis in Sicily: molecular characterization of
Rickettsia sp. obtained from ticks and human beings (1986–2001). New
Microbiol. 2005;28(4):377–9.
37. Beninati T, Genchi C, Torina A, Caracappa S, Bandi C, Lo N. Rickettsiae in
ixodid ticks, Sicily. Emerg Infect Dis. 2005;11(3):509–11.
38. Eremeeva ME, Stromdahl EY. Short report: New spotted fever group
rickettsia in a Rhipicephalus turanicus tick removed from a child in eastern
Sicily, Italy. Am J Trop Med Hyg. 2011;84(1):99–101.
39. Vitale G, Mansuelo S, Rolain JM, Raoult D. Rickettsia massiliae human
isolation. Emerg Infect Dis. 2006;12(1):174–5.
40. Parola P, Socolovschi C, Jeanjean L, Bitam I, Fournier PE, Sotto A, et al.
Warmer weather linked to tick attack and emergence of severe rickettsioses.
PLoS Negl Trop Dis. 2008;2(11):e338.
41. Garcia-Garcia JC, Portillo A, Nunez MJ, Santibanez S, Castro B, Oteo JA.
A patient from Argentina infected with Rickettsia massiliae. Am J Trop Med
Hyg. 2010;82(4):691–2.
42. Beeler E, Abramowicz KF, Zambrano ML, Sturgeon MM, Khalaf N, Hu R, et al.
A focus of dogs and Rickettsia massiliae-infected Rhipicephalus sanguineus in
California. Am J Trop Med Hyg. 2011;84(2):244–9.
Solano-Gallego et al. Parasites & Vectors  (2015) 8:216 Page 10 of 1043. Marquez FJ, Rodriguez-Liebana JJ, Soriguer RC, Muniain MA, Bernabeu-Wittel M,
Caruz A, et al. Spotted fever group Rickettsia in brown dog ticks Rhipicephalus
sanguineus in southwestern Spain. Parasitol Res. 2008;103(1):119–22.
44. Mura A, Masala G, Tola S, Satta G, Fois F, Piras P, et al. First direct detection
of rickettsial pathogens and a new rickettsia, ‘Candidatus Rickettsia barbariae’,
in ticks from Sardinia. Italy Clin Microbiol Infect. 2008;14(11):1028–33.
45. Harrus S, Perlman-Avrahami A, Mumcuoglu KY, Morick D, Baneth G. Molecular
detection of Rickettsia massiliae, Rickettsia sibirica mongolitimonae and Rickettsia
conorii israelensis in ticks from Israel. Clin Microbiol Infect. 2011;17(2):176–80.
46. Sarih M, Socolovschi C, Boudebouch N, Hassar M, Raoult D, Parola P. Spotted
fever group rickettsiae in ticks, Morocco. Emerg Infect Dis. 2008;14(7):1067–73.
47. Pons I, Nogueras MM, Sanfeliu I, Ortuno A, Segura F. Serological evidence of
infection with Bar29 in dog population of Catalonia, in the northeast of Spain.
5th International Meeting on Rickettsiae and Rickettsial Diseases, Marseille,
France. Abstract book. 2008.
48. Cardenosa N, Segura F, Raoult D. Serosurvey among Mediterranean spotted
fever patients of a new spotted fever group rickettsial strain (Bar29).
Eur J Epidemiol. 2003;18(4):351–6.
49. Bernabeu-Wittel M, del Toro MD, Nogueras MM, Muniain MA, Cardenosa N,
Segura F, et al. Presence of human past infections due to the Bar29 rickettsial
strain in Southern Spain. J Infect. 2006;52(4):e117–9.
50. Ortuno A, Pons I, Nogueras MM, Castella J, Segura F. The dog as an epidemiological
marker of Rickettsia conorii infection. Clin Microbiol Infect. 2009;15 Suppl 2:241–2.
51. Segura-Porta F, Diestre-Ortin G, Ortuno-Romero A, Sanfeliu-Sala I, Font-Creus
B, Munoz-Espin T, et al. Prevalence of antibodies to spotted fever group rickettsiae
in human beings and dogs from and endemic area of Mediterranean spotted
fever in Catalonia, Spain. Eur J Epidemiol. 1998;14(4):395–8.
52. Otranto D, Dantas-Torres F. Canine and feline vector-borne diseases in Italy:
current situation and perspectives. Parasit Vectors. 2010;3:2.
53. Otranto D, Testini G, Dantas-Torres F, Latrofa MS, Diniz PP, de Caprariis D, et al.
Diagnosis of canine vector-borne diseases in young dogs: a longitudinal study.
J Clin Microbiol. 2010;48(9):3316–24.
54. Rene-Martellet M, Lebert I, Chene J, Massot R, Leon M, Leal A, et al. Diagnosis
and incidence risk of clinical canine monocytic ehrlichiosis under field conditions
in Southern Europe. Parasit Vectors. 2015;8(1):3.
55. Rojas A, Rojas D, Montenegro V, Gutierrez R, Yasur-Landau D, Baneth G.
Vector-borne pathogens in dogs from Costa Rica: first molecular description
of Babesia vogeli and Hepatozoon canis infections with a high prevalence of
monocytic ehrlichiosis and the manifestations of co-infection. Vet Parasitol.
2014;199(3–4):121–8.
56. Baneth G, Harrus S, Gal A, Aroch I. Canine vector-borne co-infections:
Ehrlichia canis and Hepatozoon canis in the same host monocytes. Vet Parasitol.
2015;208:30–4.
57. Andrade GB, Barreto WT, Santos LL, Ribeiro LR, Macedo GC, Sousa KC, et al.
Pathology of dogs in Campo Grande, MS, Brazil naturally co-infected with
Leishmania infantum and Ehrlichia canis. Rev Bras Parasitol Vet.
2014;23(4):509–15.
58. Harrus S, Kass PH, Klement E, Waner T. Canine monocytic ehrlichiosis: a
retrospective study of 100 cases, and an epidemiological investigation of
prognostic indicators for the disease. Vet Rec. 1997;141(14):360–3.
59. Mylonakis ME, Koutinas AF, Breitschwerdt EB, Hegarty BC, Billinis CD, Leontides
LS, et al. Chronic canine ehrlichiosis (Ehrlichia canis): a retrospective study of 19
natural cases. J Am Anim Hosp Assoc. 2004;40(3):174–84.
60. Little SE. Ehrlichiosis and anaplasmosis in dogs and cats. Vet Clin North Am
Small Anim Pract. 2010;40(6):1121–40.
61. de la Fuente J, Torina A, Naranjo V, Nicosia S, Alongi A, La Mantia F, et al.
Molecular characterization of Anaplasma platys strains from dogs in
Sicily,Italy. BMC Vet Res. 2006;2:24.
62. Solano-Gallego L, Baneth G. Babesiosis in dogs and cats-Expanding parasitological
and clinical spectra. Vet Parasitol. 2011;181(1):48–60.
63. Salem NY, Farag HS. Clinical, Hematologic, and Molecular Findings in Naturally
Occurring Babesia canis vogeli in Egyptian Dogs. Vet Med Internat.
2014;2014:270345.
64. Baneth G. Perspectives on canine and feline hepatozoonosis. Vet Parasitol.
2011;181(1):3–11.
65. Otranto D, Dantas-Torres F, Weigl S, Latrofa MS, Stanneck D, Decaprariis D,
et al. Diagnosis of Hepatozoon canis in young dogs by cytology and PCR.
Parasit Vectors. 2011;4:55.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
